Zydus Wellness Share Price

  • 2,002.30-63.40 (-3.07%)
  • Volume: 2,85,533
  • Closed
  • Last Updated On: 20 Jun, 2025, 03:49 PM IST
Loading...
Zydus Wellness Share Price
  • 2,002.30-63.40 (-3.07%)
  • Volume: 2,85,533
Advertisment

Zydus Wellness share price insights

View All
  • Company announced a dividend of Rs 6.0 per share on May 19, 2025 with record date of Jul 11, 2025.

  • Company witnessed QoQ revenue growth of 96.24%, which is highest in the last 3 years. (Source: Consolidated Financials)

  • Company's annual revenue growth of 16.26% outperformed its 3 year CAGR of 10.36%. (Source: Consolidated Financials)

  • Company has spent less than 1% of its operating revenues towards interest expenses and 8.76% towards employee cost in the year ending Mar 31, 2025. (Source: Consolidated Financials)

  • Zydus Wellness Ltd. share price moved down by -3.07% from its previous close of Rs 2,065.70. Zydus Wellness Ltd. stock last traded price is 2,002.30

    Share PriceValue
    Today/Current/Last2,002.30
    Previous Day2,065.702,067.15

InsightsZydus Wellness

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Key Metrics

    PE Ratio
    (x)
    36.73
    EPS - TTM
    (₹)
    54.52
    MCap
    (₹ Cr.)
    12,741.06
    Sectoral MCap Rank
    19
    PB Ratio
    (x)
    2.32
    Div Yield
    (%)
    0.30
    Face Value
    (₹)
    10.00
    Beta

    Beta

    1 Month1.02
    3 Months0.64
    6 Months0.39
    1 Year0.63
    3 Years0.61

    1.02
    VWAP
    (₹)
    2,026.38
    52W H/L
    (₹)
    2,484.00 / 1,493.20

    Zydus Wellness Share Price Returns

    1 Day-3.07%
    1 Week4.69%
    1 Month4.24%
    3 Months19.98%
    1 Year6.07%
    3 Years32.26%
    5 Years58.25%

    ET Stock ScreenersTop Score Companies

    Check whether Zydus Wellness belongs to analysts' top-rated companies list?

    View Stock Screeners

    Zydus Wellness Share Analysis

    Unlock Stock Score, Analyst' Ratings & Recommendations

    Share Analysis Non Prime User
    • View Stock Score on a 10-point scale
    • See ratings on Earning, Fundamentals, Valuation, Risk & Price
    • Check stock performance
    JOIN ET PRIME

    Zydus Wellness Share Recommendations

    Recent Recos

    STRONG BUY

    Current

    Mean Recos by 5 Analysts

    Strong
    Sell
    SellHoldBuyStrong
    Buy
    • Target₹2000
    • OrganizationICICI Securities
    • ADD
    • Target₹1910
    • OrganizationAnand Rathi
    • BUY

    Analyst Trends

    RatingsCurrent1 Week Ago1 Month Ago3 Months Ago
    Strong Buy4442
    Buy---2
    Hold1111
    Sell----
    Strong Sell----
    # Analysts5555

    Zydus Wellness Financials

    • Insights

      • Quarterly Topline Performance

        Company witnessed QoQ revenue growth of 96.24%, which is highest in the last 3 years. (Source: Consolidated Financials)
      • Beating 3 Yr Revenue CAGR

        Company's annual revenue growth of 16.26% outperformed its 3 year CAGR of 10.36%. (Source: Consolidated Financials)
      Quarterly | AnnualMar 2025Dec 2024Sep 2024Jun 2024Mar 2024
      Total Income913.90465.70496.90846.00786.60
      Total Income Growth (%)96.24-6.28-41.267.5593.46
      Total Expenses736.30452.30472.30690.80626.10
      Total Expenses Growth (%)62.79-4.23-31.6310.3357.87
      EBIT177.6013.4024.60155.20160.50
      EBIT Growth (%)1,225.37-45.53-84.15-3.301,505.00
      Profit after Tax (PAT)171.906.4020.90147.70150.30
      PAT Growth (%)2,585.94-69.38-85.85-1.730.01
      EBIT Margin (%)19.432.884.9518.3520.40
      Net Profit Margin (%)18.811.374.2117.4619.11
      Basic EPS (₹)27.011.013.2823.2123.62
      Quarterly | AnnualMar 2025Dec 2024Sep 2024Jun 2024Mar 2024
      Total Income77.8091.5067.4068.2067.80
      Total Income Growth (%)-14.9735.76-1.170.59-0.88
      Total Expenses69.5074.5056.7059.0056.50
      Total Expenses Growth (%)-6.7131.39-3.904.424.82
      EBIT8.3017.0010.709.2011.30
      EBIT Growth (%)-51.1858.8816.30-18.58-22.07
      Profit after Tax (PAT)4.7011.708.006.207.40
      PAT Growth (%)-59.8346.2529.03-16.22-28.16
      EBIT Margin (%)10.6718.5815.8813.4916.67
      Net Profit Margin (%)6.0412.7911.879.0910.91
      Basic EPS (₹)0.741.841.260.971.16
      Quarterly | Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Total Revenue2,722.502,341.702,259.652,019.501,875.61
      Total Revenue Growth (%)16.263.6311.897.675.52
      Total Expenses2,369.602,067.401,958.741,713.481,631.27
      Total Expenses Growth (%)14.625.5514.315.041.19
      Profit after Tax (PAT)346.90266.90310.37308.87118.73
      PAT Growth (%)29.97-14.010.49160.14-16.22
      Operating Profit Margin (%)13.4712.8114.0516.5017.57
      Net Profit Margin (%)12.8011.4613.7615.376.36
      Basic EPS (₹)54.5241.9448.7848.5419.55
      Quarterly | Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Total Revenue304.90262.80265.00231.65180.63
      Total Revenue Growth (%)16.02-0.8314.4028.25-31.30
      Total Expenses264.20218.00217.83226.43241.70
      Total Expenses Growth (%)21.190.08-3.80-6.32-23.88
      Profit after Tax (PAT)30.6033.7066.4212.70-182.14
      PAT Growth (%)-9.20-49.26422.99--
      Operating Profit Margin (%)15.4419.3619.213.3411.93
      Net Profit Margin (%)10.4513.7626.415.87-160.01
      Basic EPS (₹)4.815.3010.442.00-29.99

      All figures in Rs Cr, unless mentioned otherwise

    • Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Total Assets6,441.906,148.405,833.055,692.185,666.43
      Total Assets Growth (%)4.775.412.470.451.37
      Total Liabilities770.30790.90710.40848.151,098.64
      Total Liabilities Growth (%)-2.6011.33-16.24-22.80-48.40
      Total Equity5,671.605,357.505,122.654,844.034,567.79
      Total Equity Growth (%)5.864.585.756.0531.99
      Current Ratio (x)1.481.621.311.061.10
      Total Debt to Equity (x)0.030.060.060.080.12
      Contingent Liabilities0.00312.90362.70336.65327.40
      Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Total Assets4,213.504,115.804,066.834,090.504,116.45
      Total Assets Growth (%)2.371.20-0.58-0.63-14.29
      Total Liabilities178.9079.9032.5590.3297.16
      Total Liabilities Growth (%)123.90145.47-63.96-7.04-93.88
      Total Equity4,034.604,035.904,034.284,000.184,019.29
      Total Equity Growth (%)-0.030.040.85-0.4825.03
      Current Ratio (x)0.451.765.961.391.41
      Total Debt to Equity (x)0.030.010.000.010.01
      Contingent Liabilities0.0011.8011.2211.237.67

      All figures in Rs Cr, unless mentioned otherwise

    • Insights

      • Increase in Cash from Investing

        Company has used Rs 223.6 cr for investing activities which is an YoY increase of 1058.55%. (Source: Consolidated Financials)
      Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Net Cash flow from Operating Activities380.00246.4091.71236.85286.51
      Net Cash used in Investing Activities-223.60-19.30-84.84-58.93-10.41
      Net Cash flow from Financing Activities-186.30-25.70-138.49-233.82-216.21
      Net Cash Flow-29.90201.40-131.62-55.9059.89
      Closing Cash & Cash Equivalent66.70239.5038.18196.82252.72
      Closing Cash & Cash Equivalent Growth (%)-72.15527.29-80.60-22.1231.06
      Total Debt/ CFO (x)0.491.313.191.611.92
      Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Net Cash flow from Operating Activities45.7026.0036.67-16.27-51.95
      Net Cash used in Investing Activities-96.30-47.200.6639.33816.14
      Net Cash flow from Financing Activities43.4015.40-79.33-37.69-709.99
      Net Cash Flow-7.20-5.80-42.00-14.6354.20
      Closing Cash & Cash Equivalent2.009.6015.3569.3784.00
      Closing Cash & Cash Equivalent Growth (%)-79.17-37.46-77.87-17.42181.88
      Total Debt/ CFO (x)2.821.920.00-2.83-0.96

      All figures in Rs Cr, unless mentioned otherwise

    • Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Return on Equity (%)6.114.986.056.372.59
      Return on Capital Employed (%)6.405.546.166.736.70
      Return on Assets (%)5.384.345.325.422.09
      Interest Coverage Ratio (x)32.7813.4221.2713.924.22
      Asset Turnover Ratio (x)0.430.390.050.040.02
      Price to Earnings (x)30.6735.0931.8530.96106.38
      Price to Book (x)1.871.751.931.972.75
      EV/EBITDA (x)27.3129.3129.5827.4836.37
      EBITDA Margin (%)14.5113.8315.1617.6718.92
      Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Return on Equity (%)0.750.831.640.31-4.53
      Return on Capital Employed (%)1.101.171.190.180.33
      Return on Assets (%)0.720.811.630.31-4.42
      Interest Coverage Ratio (x)10.8719.6245.464.990.23
      Asset Turnover Ratio (x)0.070.060.060.050.03
      Price to Earnings (x)357.14277.78149.25769.23-68.97
      Price to Book (x)2.632.322.442.393.12
      EV/EBITDA (x)219.99184.22189.98946.22732.94
      EBITDA Margin (%)16.7120.8320.604.6615.00

    Financial InsightsZydus Wellness

    • Income (P&L)
    • Cash Flow
      • Quarterly Topline Performance

        Company witnessed QoQ revenue growth of 96.24%, which is highest in the last 3 years. (Source: Consolidated Financials)

      • Beating 3 Yr Revenue CAGR

        Company's annual revenue growth of 16.26% outperformed its 3 year CAGR of 10.36%. (Source: Consolidated Financials)

      • Increase in Cash from Investing

        Company has used Rs 223.6 cr for investing activities which is an YoY increase of 1058.55%. (Source: Consolidated Financials)

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Zydus Wellness Share Price Forecast

    • Get multiple analysts’ prediction on Zydus Wellness

      Stock Forecast Non Prime User
      • High, low, medium predictions for Price
      • Upcoming predictions for Revenue
      • Details about company earnings
      START FREE TRIAL
    • Get multiple analysts’ prediction on Zydus Wellness

      Stock Forecast Non Prime User
      • High, low, medium predictions for Price
      • Upcoming predictions for Revenue
      • Details about company earnings
      START FREE TRIAL
    • Get multiple analysts’ prediction on Zydus Wellness

      Stock Forecast Non Prime User
      • High, low, medium predictions for Price
      • Upcoming predictions for Revenue
      • Details about company earnings
      START FREE TRIAL

    Zydus Wellness Technicals

    • Stock doesn't have any Buy/Sell Signals.

    • 42%
      Positive Movement since
      1st Jan 2005 on basis
      58%
      Negative Movement since
      1st Jan 2005 on basis
      Exclude
    • Pivot Levels

      R1R2R3PIVOTS1S2S3
      Classic-------

      Average True Range

      5 DAYS14 DAYS28 DAYS
      ATR---

    Zydus Wellness Peer Comparison

    Peers InsightsZydus Wellness

      Do you find these insights useful?

      • hate it

      • meh

      • love it

      Zydus Wellness Shareholding Pattern

      • Loading...
        Showing Zydus Wellness Shareholding as on Mar 2025
        CategoryMar 2025Dec 2024Sep 2024Jun 2024
        Promoters69.6369.6269.6269.62
        Pledge0.000.000.000.00
        FII3.293.373.363.29
        DII19.7520.1120.3619.43
        Mutual Funds11.6111.8711.978.38
        Others7.326.896.657.65
      • Showing Shareholding as on Mar 2025
        CategoryNo. of SharesPercentage% Change QoQ
        Promoters4,43,10,14169.63 %0.00
        Pledge00.00 %0.00
        FII20,94,5573.29 %-0.08
        DII1,25,72,46919.75 %-0.35
        MF73,87,22811.61 %-0.25
        Others46,54,9777.32 %0.43

      Zydus Wellness MF Ownership

      MF Ownership as on 31 May 2025

      Zydus Wellness Corporate Actions

      • Meeting DateAnnounced onPurposeDetails
        May 19, 2025May 09, 2025Board MeetingAudited Results, Dividend & Stock Split
        Feb 04, 2025Jan 23, 2025Board MeetingQuarterly Results
        Nov 11, 2024Oct 29, 2024Board MeetingQuarterly Results
        Aug 02, 2024Jul 18, 2024Board MeetingQuarterly Results
        Aug 02, 2024May 14, 2024AGM-
      • TypeDividendDividend per ShareEx-Dividend DateAnnounced on
        Final60%6.0Jul 11, 2025May 19, 2025
        Final50%5.0Jul 19, 2024May 14, 2024
        Final50%5.0Jul 21, 2023May 17, 2023
        Final50%5.0Jul 14, 2022May 17, 2022
        Final50%5.0Jul 14, 2021May 10, 2021
      • No other corporate actions details are available.

      About Zydus Wellness

      Zydus Wellness Ltd., incorporated in the year 1994, is a Mid Cap company (having a market cap of Rs 12,741.06 Crore) operating in FMCG sector. Zydus Wellness Ltd. key Products/Revenue Segments include Food Products and Other Operating Revenue for the year ending 31-Mar-2024. Show More

      • Executives

      • Auditors

      • SP

        Sharvil P Patel

        Chairman
        TG

        Tarun G Arora

        WholeTime Director & CEO
        GN

        Ganesh N Nayak

        Non Executive Director
        AP

        Ashish P Bhargava

        Nominee Director
        Show More
      • Mukesh M Shah & Co.
        Dhirubhai Shah & Co. LLP

      FAQs about Zydus Wellness share

      • 1. What is Zydus Wellness share price and what are the returns for Zydus Wellness share?
        Zydus Wellness share price is Rs 2,002.30 as on 20 Jun, 2025, 03:59 PM IST. Zydus Wellness share price is down by 3.07% based on previous share price of Rs. 2054.3. In last 1 Month, Zydus Wellness share price moved up by 4.24%.
      • 2. What's the market capitalization of Zydus Wellness?
        Zydus Wellness share has a market capitalization of Rs 12,741.06 Cr. Within FMCG sector, it's market cap rank is 19.
      • 3. What are the returns for Zydus Wellness share?
        Return Performance of Zydus Wellness Shares:
        • 1 Week: Zydus Wellness share price moved up by 4.69%
        • 1 Month: Zydus Wellness share price moved up by 4.24%
        • 3 Month: Zydus Wellness share price moved up by 19.98%
        • 6 Month: Zydus Wellness share price moved up by 4.76%
      • 4. What is Zydus Wellness's 52 week high / low?
        Zydus Wellness share price saw a 52 week high of Rs 2,484.00 and 52 week low of Rs 1,493.20.
      • 5. What is the PE & PB ratio of Zydus Wellness?
        The PE ratio of Zydus Wellness stands at 37.89, while the PB ratio is 2.32.

      Trending in Markets

      Top Gainers As on 03:59 PM | 20 Jun 2025

      GRSE3,287.60
      309.30 (10.39%)
      BEML4,639.50
      432.90 (10.29%)
      ABB Power18,684.00
      1650.00 (9.69%)
      Swiggy389.50
      33.40 (9.38%)
      MCX India8,085.00
      574.00 (7.64%)

      Top Losers As on 03:59 PM | 20 Jun 2025

      Tata Teleservices63.62
      -13.28 (-17.27%)
      Hindustan Zinc438.60
      -78.65 (-15.21%)
      AstraZeneca8,871.00
      -1324.00 (-12.99%)
      International Gemmol345.95
      -45.05 (-11.52%)
      Concord Biotech Ltd.1,837.30
      -226.30 (-10.97%)

      DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

      DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

      By using this site, you agree to the Terms of Service and Privacy Policy.

      The Economic Times
      OSZAR »